Poseida Therapeutics

Poseida Therapeutics

Multiple myeloma, MM (NCT04960579)
Sponsors:
Poseida Therapeutics, Inc.
Indicator
IND Enabling
Phase I
Phase II
Phase III
close
Search CRISPR Medicine